Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2025-12-25 @ 10:21 PM
Study NCT ID:
NCT03594058
Status:
COMPLETED
Last Update Posted:
2020-03-02
First Post:
2018-07-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)
Sponsor:
Velicept Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-02
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-09
First Submit QC Date:
None
Study First Post Date:
2018-07-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-03-02
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-02-27
Last Update Post Date:
2020-03-02
Last Update Post Date Type:
ACTUAL